BioCentury
ARTICLE | Company News

Novartis gets conditional approvable letter for Zelmac

August 14, 2000 7:00 AM UTC

Novartis (SWX:NOVN; NVS) said it received an approvable letter from the FDA for Zelmac tegaserod to treat abdominal pain/discomfort and constipation in women with constipation-predominant irritable bo...